The Classification of Glomerulonephritis in Systemic Lupus Erythematosus RevisitedJan J. Weening, Michio Nagata, Vivette D. D’Agati et al.|Journal of the American Society of Nephrology|2004Cited by 2k
The classification of glomerulonephritis in systemic lupus erythematosus revisitedJan J. Weening, Michio Nagata, Vivette D. D’Agati et al.|Kidney International|2004Cited by 1.7k
Erratum: The classification of glomerulonephritis in systemic lupus ereythematosus revisited (Kidney International (2004) 65 (521-530))J. J. Weening, M. Nagata, Vivette D. D’Agati et al.|Kidney International|2004Cited by 9
ABS0935 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL TO EVALUATE THE PRELIMINARY EFFICACY, SAFETY OF REPEATED ADMINISTRATION OF XELIGEKIMAB (GR1501) INJECTION IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITISDong Xu, Norella Kong, Yuzhou Zhao et al.|Annals of the Rheumatic Diseases|2025Cited by 1
The classification of glomerulonephritis in systemic lupus erythematosus revisitedSurya V. Seshan, Franco Ferrario, Ellen M. Ginzler et al.|UNC Libraries|2021Cited by 0